NYU's Perlmutter Cancer Center & the Technion launch global cancer research initiative
(NYU Langone Medical Center / New York University School of Medicine) Drug-carrying 'nanoghosts' that battle melanoma and new treatments for malignant mesothelioma will be the focus of the first joint research projects led by NYU Langone Medical Center and the Technion-Israel Institute of Technology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Asbestosis | Cancer | Cancer & Oncology | Melanoma | Mesothelioma | Middle East Health | Nanotechnology | New York University | Skin Cancer